ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,568Medicare Part D Prescriptions Filled, Including Refills

Rank: 297 out of 1499

$535K Total Retail Price of All Prescriptions

Rank: 299 out of 1499

502 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 502 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 502 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 6,396 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 516 308 1 3
LISINOPRIL 402 219 2 1
METFORMIN HCL 356 208 3 8
HYDROCODONE-ACETAMINOPHEN 349 192 S3 4 4
OMEPRAZOLE 331 227 5 5
FUROSEMIDE 288 197 6 7
LEVOTHYROXINE SODIUM 274 176 7 2
AMLODIPINE BESYLATE 268 211 8 6
HYDROCHLOROTHIAZIDE 234 174 9 9
POTASSIUM CHLORIDE 214 127 10 11
METOPROLOL TARTRATE 191 171 11 10
WARFARIN SODIUM 168 104 12 12
SERTRALINE HCL 159 107 13 24
ZOLPIDEM TARTRATE 143 82 14 23
GLIMEPIRIDE 139 81 15 38
CITALOPRAM HBR 135 76 16 14
RANITIDINE HCL 123 22 17 15
ATORVASTATIN CALCIUM 109 73 18 17
GABAPENTIN 99 56 19 13
DIOVAN 96 71 20 58
PROAIR HFA 95 43 21 30
LANTUS 87 65 22 46
CARVEDILOL 85 67 23 22
ALLOPURINOL 84 34 24 36
TAMSULOSIN HCL 84 65 24 29
CRESTOR 80 71 26 34
CLOPIDOGREL 78 57 27 39
POLYETHYLENE GLYCOL 3350 76 52 28 52
PREDNISONE 76 36 28 42
GLIPIZIDE 73 40 30 64
ISOSORBIDE MONONITRATE ER 73 73 30 51
LANTUS SOLOSTAR 72 34 32 89
METOPROLOL SUCCINATE 72 55 32 20
ATENOLOL 71 42 34 21
RAMIPRIL 70 57 35 127
ENALAPRIL MALEATE 69 55 36 75
AZITHROMYCIN 64 40 37 45
NAPROXEN 64 46 37 63
METHYLPREDNISOLONE 64 47 37 135
TRAZODONE HCL 63 41 40 32
INSULIN SYRINGE 62 37 41 102
TRAMADOL HCL 62 20 41 16
LOVASTATIN 61 36 43 19
SINGULAIR 59 22 44 67
NEXIUM 59 0 44 28
PLAVIX 58 41 46 54
NIFEDIPINE ER 56 16 47 156
COMBIVENT 55 40 48 78
MELOXICAM 55 12 48 27
IBUPROFEN 55 19 48 70
PROPRANOLOL HCL 54 24 51 115
OXYCODONE HCL-ACETAMINOPHEN 51 14 S2 52 81
PREMARIN 50 33 R 53 139
DIOVAN HCT 50 42 53 122
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 24, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.